(Q33378805)

26 July 2017

title

Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children (English)

1 reference

26 July 2017

1 reference

M Isabel Gonzalez-Tome

1

1 reference

26 July 2017

Jose Tomas Ramos Amador

2

1 reference

26 July 2017

M Jose Mellado Peña

3

1 reference

26 July 2017

M Luisa Navarro Gomez

4

1 reference

26 July 2017

Pablo Rojo Conejo

5

1 reference

26 July 2017

Pablo Martin Fontelos

6

1 reference

26 July 2017

language of work or name

1 reference

22 October 2008

1 reference

26 July 2017

published in

BMC Infectious Diseases

1 reference

26 July 2017

volume

8

1 reference

26 July 2017

page(s)

144

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

copyright license

start time

22 October 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-8-144

0 references

cites work

Impact of nevirapine on lipid metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584640

Effect of exercise and strength training on cardiovascular status in HIV-infected patients receiving highly active antiretroviral therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584640

Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children treated with protease inhibitors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584640

Metabolic complications of antiretroviral therapy in children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584640

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584640

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2584640

Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Lipodystrophy syndrome in human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Metabolic complications of HIV therapy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

A 48-week, randomized, open-label comparison of three abacavir-based substitution approaches in the management of dyslipidemia and peripheral lipoatrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-8-144

[Decreased bone mineral density in HIV-infected children receiving highly active antiretroviral therapy]

21 January 2018

1 reference

12 December 2020

Bone mass in children: normative values for the 2-20-year-old population

1 reference

12 December 2020

Epidemiological and clinical aspects of the metabolic complications of HIV infection the fat redistribution syndrome

1 reference

12 December 2020

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

12 December 2020

The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy

1 reference

12 December 2020

Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study

1 reference

12 December 2020

Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2334-8-144

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference